Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) have earned a consensus rating of “Hold” from the twenty-one analysts that are currently covering the stock. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and eleven have assigned a buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $14.77.

A number of research firms have recently weighed in on MDRX. Cantor Fitzgerald reiterated a “neutral” rating and issued a $13.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. Maxim Group reiterated a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. Bank of America Corp began coverage on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. They issued a “neutral” rating and a $14.00 price objective on the stock. Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Wednesday, April 19th. Finally, Wells Fargo & Co upgraded shares of Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating in a research note on Monday, March 27th.

In other Allscripts Healthcare Solutions news, SVP Brian Farley sold 15,000 shares of the stock in a transaction on Thursday, March 23rd. The shares were sold at an average price of $11.63, for a total transaction of $174,450.00. Following the transaction, the senior vice president now directly owns 217,861 shares of the company’s stock, valued at $2,533,723.43. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, President Richard J. Poulton sold 25,000 shares of the stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $12.06, for a total transaction of $301,500.00. Following the transaction, the president now directly owns 412,488 shares in the company, valued at $4,974,605.28. The disclosure for this sale can be found here. Company insiders own 0.75% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in Allscripts Healthcare Solutions by 3.7% in the first quarter. Vanguard Group Inc. now owns 14,642,919 shares of the software maker’s stock valued at $185,672,000 after buying an additional 519,798 shares during the last quarter. Iridian Asset Management LLC CT increased its position in Allscripts Healthcare Solutions by 26.5% in the fourth quarter. Iridian Asset Management LLC CT now owns 13,268,624 shares of the software maker’s stock valued at $135,473,000 after buying an additional 2,781,219 shares during the last quarter. Westpac Banking Corp increased its position in Allscripts Healthcare Solutions by 0.7% in the third quarter. Westpac Banking Corp now owns 7,525,766 shares of the software maker’s stock valued at $99,114,000 after buying an additional 54,701 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Allscripts Healthcare Solutions by 9.4% in the first quarter. Dimensional Fund Advisors LP now owns 7,227,789 shares of the software maker’s stock valued at $91,648,000 after buying an additional 621,620 shares during the last quarter. Finally, Fiduciary Management Inc. WI increased its position in Allscripts Healthcare Solutions by 28.5% in the first quarter. Fiduciary Management Inc. WI now owns 6,045,110 shares of the software maker’s stock valued at $76,652,000 after buying an additional 1,341,870 shares during the last quarter.

WARNING: This story was published by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/05/22/allscripts-healthcare-solutions-inc-mdrx-given-consensus-recommendation-of-hold-by-analysts.html.

Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up 0.25% during midday trading on Monday, hitting $11.93. 1,292,931 shares of the stock were exchanged. The firm’s 50-day moving average is $12.15 and its 200-day moving average is $11.58. The stock’s market cap is $2.16 billion. Allscripts Healthcare Solutions has a 12 month low of $9.80 and a 12 month high of $15.17.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, May 4th. The software maker reported $0.10 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.09 by $0.01. The firm had revenue of $415 million for the quarter, compared to analyst estimates of $415.20 million. Allscripts Healthcare Solutions had a negative net margin of 0.14% and a positive return on equity of 5.79%. The business’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.13 earnings per share. Equities research analysts predict that Allscripts Healthcare Solutions will post $0.62 earnings per share for the current year.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

12 Month Chart for NASDAQ:MDRX

Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.